Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life-saving potential of stem cells to families nationwide and internationally, is pleased to announce that Chairman, CEO and co-founder Matthew Schissler and Dr. Geoffrey O'Neill, Vice President, Operations, will appear for one hour live on "Go Rogue & Get Rich" on The VoiceAmerica Radio Network.
Both Mr. Schissler and Dr. O'Neill will first describe the cord blood collection, process and storage procedure, and take questions about cord blood stem cells, including processing and storage, from the audience during the live international radio show at 2 p.m. Pacific, 5 p.m. Eastern on Monday, October 25 on the VoiceAmerica.com Business Channel (Go Rogue & Get Rich!) http://www.voiceamerica.com.
"We are honored that Kevin asked us to be on the show. We recognize his show is geared towards building businesses. Any opportunity to preach the cord blood gospel is welcome by CBAI," Mr. Schissler said.
Kevin Lehmann, who hosts the program, is well known for his business acumen and advocacy for entrepreneurship and free enterprise. He successfully launched the largest lead generation and sales and marketing training company in Network Marketing history, helping to revolutionize the sector with a high-tech/high-touch philosophy.
Mr. Schissler co-founded Cord Blood America, Inc. in 2003 with the vision of bringing the life-saving potential of stem cells to families in the U.S. and worldwide. He has positioned the company to focus on strategic organic growth, accretive acquisitions and diversifying into new, undiscovered stem cell processing and storage opportunities.
Dr. O'Neill, who has 25 years experience in the stem cell industry, has published 78 papers on the sector. He was the recipient of the prestigious Jean Julliard Prize for Research from the International Society of Blood Transfusion and the International Society of Hematology.
"We are looking forward to this opportunity to tell a national audience about the accomplishments and future plans for Cord Blood America, which now has an international presence, with affiliations in China, South America and throughout Europe," Mr. Schissler said.
Non-invasive blood test shows 83% sensitivity in detecting colorectal cancer, offering hope for early diagnosis